Nine Chapters Capital Management’s Boston Scientific BSX Stock Holding History

Nine Chapters Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-71,000	Closed	-$1.17M	–	86
2015 Q3	$1.17M	Buy	+71,000	New	+$1.21M	0.1%	296
2015 Q2	–	Sell	-58,100	Closed	-$1.03M	–	980
2015 Q1	$1.03M	Sell	58,100 -349,300	-86%	-$5.52M	0.09%	366
2014 Q4	$5.4M	Buy	407,400 +62,200	+18%	+$795K	0.47%	36
2014 Q3	$4.08M	Buy	345,200 +156,100	+83%	+$1.97M	0.36%	55
2014 Q2	$2.42M	Buy	189,100 +26,200	+16%	+$341K	0.2%	140
2014 Q1	$2.2M	Buy	162,900 +75,900	+87%	+$996K	0.26%	91
2013 Q4	$1.05M	Buy	87,000 +8,600	+11%	+$102K	0.11%	292
2013 Q3	$920K	Buy	78,400 +33,000	+73%	+$357K	0.11%	274
2013 Q2	$421K	Buy	+45,400	New	+$385K	0.07%	379

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nine Chapters Capital Management's BSX Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Boston Scientific (BSX) in Q4 2015, closing a stake of 71,000 shares — an estimated $1.17M sold.

Nine Chapters Capital Management first reported a position in BSX in Q2 2013 and held it in 9 quarters. The position peaked at $5.4M in Q4 2014. 502 funds tracked by Wall St. Rank hold BSX as of Q4 2015.

Nine Chapters Capital Management reported no remaining Boston Scientific position as of Q4 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 71,000 Boston Scientific shares in Q4 2015, an estimated $1.17M.
Nine Chapters Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 9 quarters.
Nine Chapters Capital Management's Boston Scientific position peaked at $5.4M in Q4 2014.
502 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.